Federal Register / Vol. 87, No. 66 / Wednesday, April 6, 2022 / Notices 19973 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA 950] 

Importer of Controlled Substances 

Application: Meridian Medical 

Technologies 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Meridian Medical 

Technologies has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before May 6, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 6, 2022. 

ADDRESSES: The DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on December 6, 2021, 

Meridian Medical Technologies, 2555 

Hermelin Drive, Saint Louis, Missouri 

63144, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Morphine ......................... 9300 II 

The company manufactures a product 

containing morphine in the United 

States. The company exports this 

product to customers around the world. 

The company has been asked to ensure 

that its product, which is sold to 

European customers, meets the 

standards established by the European 

Pharmacopeia, administered by the 

Directorate for the quality of Medicines 

(EDQM). In order to ensure that its 

product will meet European 

specifications, the company seeks to 

import morphine supplied by EDQM for 

use as reference standards. No other 

activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–07207 Filed 4–5–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Parole Commission 

Sunshine Act Meeting 

DATE AND TIME: Thursday April 14, 2022, 

at 2 p.m. 

PLACE: U.S. Parole Commission, 90 K 

Street NE, 3rd Floor, Washington, DC. 

STATUS: Open. 

MATTERS TO BE CONSIDERED: 

1. Approval of October 14, 2021 

Quarterly Meeting minutes. 

2. Verbal Pandemic Updates since 

October Quarterly Meeting from the 

Acting Chairman, Commissioner, Acting 

Chief of Staff/Case Operations 

Administrator, Case Services 

Administrator, Executive Officer, and 

General Counsel. 

3. Verbal update from Jordana 

Cunningham regarding RSAT and other 

treatment programs being utilized. 

4. Update on the PAVER program. 

CONTACT PERSON FOR MORE INFORMATION: 

Jacquelyn Graham, Staff Assistant to the 

Chairman, U.S. Parole Commission, 90 

K Street NE, 3rd Floor, Washington, DC 

20530, (202) 346–7010. 

Dated: April 4, 2022. 

Patricia K. Cushwa, 

Chairman (Acting), U.S. Parole Commission. 

[FR Doc. 2022–07441 Filed 4–4–22; 4:15 pm] 

BILLING CODE 4410–31–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Workforce Innovation and Opportunity 

Act (WIOA) 2021 Lower Living 

Standard Income Level (LLSIL) 

AGENCY: Employment and Training 

Administration (ETA), Labor. 

ACTION: Notice. 

SUMMARY: Title I of WIOA requires the 

U.S. Secretary of Labor (Secretary) to 

update and publish the LLSIL tables 

annually, for uses described in the law 

(including determining eligibility for 

youth). WIOA defines the term ‘‘lowincome individual’’ as (inter alia) one 

whose total family annual income does 

not exceed the higher level of the 

poverty line or 70 percent of the LLSIL. 

This issuance provides the Secretary’s 

annual LLSIL for 2022 and references 

the current 2022 Health and Human 

Services ‘‘Poverty Guidelines.’’ 

DATES: This notice is effective April 6, 

2022. 

FOR FURTHER INFORMATION CONTACT: 

Contact Samuel Wright, Department of 

Labor, Employment and Training 

Administration, 200 Constitution 

Avenue NW, Room C–4526, 

Washington, DC 20210; Telephone: 

202–693–2870; Fax: 202–693–3015 

(these are not toll-free numbers); Email 

address: wright.samuel.e@dol.gov. 

Individuals with hearing or speech 

impairments may access the telephone 

number above via Text Telephone 

(TTY/TDD) by calling the toll-free 

Federal Information Relay Service at 1– 

877–889–5627 (TTY/TDD). 

Federal Youth Employment Program 

Information: Sara Hastings, Department 

of Labor, Employment and Training 

Administration, 200 Constitution 

Avenue NW, Room N–4464, 

Washington, DC 20210; Telephone: 

202–693–3599; Email: hastings.sara@

dol.gov. Individuals with hearing or 

speech impairments may access the 

telephone number above via TTY by 

calling the toll-free Federal Information 

Relay Service at 1–877–889–5627 (TTY/ 

TDD). 

SUPPLEMENTARY INFORMATION: The 

purpose of WIOA is to provide 


lotter on DSK11XQN23PROD with NOTICES1

I I